Stock Price
206,000.00
Daily Change
6,000.00 3.00%
Monthly
-15.75%
Yearly
9.93%
Q1 Forecast
195,060.60

Celltrion reported KRW218.78M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Akebia Therapeutics USD 2K 0 Mar/2025
Alaunos Therapeutics USD 2.21M 2.2M Sep/2025
Celltrion KRW 218.78M 1.5M Sep/2025
Dianthus Therapeutics USD 42.85M 42.82M Sep/2025
Ionis Pharmaceuticals USD 161.97M 836K Dec/2025
IQVIA Holdings USD 169.6M 700K Dec/2025
Moderna USD 391M 2M Sep/2025
Organon & Co USD 259.98M 18K Sep/2025
Revvity USD 113.38M 2.7M Dec/2025
Tectonic Therapeutic USD 14.86M 111.83K Dec/2024
Viatris USD 1.16B 6.55M Sep/2025
Xeris Pharmaceuticals USD 165.53M 165.51M Sep/2025